Style | Citing Format |
---|---|
MLA | Salami M, et al.. "Therapeutic Potential of Resveratrol in Diabetic Nephropathy According to Molecular Signaling." Current Molecular Pharmacology, vol. 15, no. 5, 2022, pp. 716-735. |
APA | Salami M, Salami R, Mafi A, Aarabi MH, Vakili O, Asemi Z (2022). Therapeutic Potential of Resveratrol in Diabetic Nephropathy According to Molecular Signaling. Current Molecular Pharmacology, 15(5), 716-735. |
Chicago | Salami M, Salami R, Mafi A, Aarabi MH, Vakili O, Asemi Z. "Therapeutic Potential of Resveratrol in Diabetic Nephropathy According to Molecular Signaling." Current Molecular Pharmacology 15, no. 5 (2022): 716-735. |
Harvard | Salami M et al. (2022) 'Therapeutic Potential of Resveratrol in Diabetic Nephropathy According to Molecular Signaling', Current Molecular Pharmacology, 15(5), pp. 716-735. |
Vancouver | Salami M, Salami R, Mafi A, Aarabi MH, Vakili O, Asemi Z. Therapeutic Potential of Resveratrol in Diabetic Nephropathy According to Molecular Signaling. Current Molecular Pharmacology. 2022;15(5):716-735. |
BibTex | @article{ author = {Salami M and Salami R and Mafi A and Aarabi MH and Vakili O and Asemi Z}, title = {Therapeutic Potential of Resveratrol in Diabetic Nephropathy According to Molecular Signaling}, journal = {Current Molecular Pharmacology}, volume = {15}, number = {5}, pages = {716-735}, year = {2022} } |
RIS | TY - JOUR AU - Salami M AU - Salami R AU - Mafi A AU - Aarabi MH AU - Vakili O AU - Asemi Z TI - Therapeutic Potential of Resveratrol in Diabetic Nephropathy According to Molecular Signaling JO - Current Molecular Pharmacology VL - 15 IS - 5 SP - 716 EP - 735 PY - 2022 ER - |